Literature DB >> 21846261

Use of Trial 1 of the Test of Memory Malingering (TOMM) as a screening measure of effort: suggested discontinuation rules.

Robin C Hilsabeck1, Shalanda N Gordon, Tammy Hietpas-Wilson, Andrea L Zartman.   

Abstract

Trial 1 of the Test of Memory Malingering (TOMM) has been suggested as a screening tool, with several possible cut-off scores proposed. The purpose of the present study was to replicate the utility of previously suggested cut-off scores and to characterize neuropsychological profiles of persons who "pass" the TOMM but obtain Trial 1 scores < 45 and of persons with cognitive disorders. A total of 229 veterans were administered the TOMM as part of a neuropsychological evaluation. Trial 1 scores ≥ 41 and ≤ 25 showed good utility as discontinuation scores for adequate and poor effort, respectively, beyond which administration of additional trials were unnecessary. Findings suggest better Trial 1 performance is significantly related to better speeded mental flexibility and memory.

Entities:  

Mesh:

Year:  2011        PMID: 21846261     DOI: 10.1080/13854046.2011.589409

Source DB:  PubMed          Journal:  Clin Neuropsychol        ISSN: 1385-4046            Impact factor:   3.535


  6 in total

1.  Failed Performance on the Test of Memory Malingering and Misdiagnosis in Individuals with Early-Onset Dysexecutive Alzheimer's Disease.

Authors:  Nick Corriveau-Lecavalier; Eva C Alden; Nikki H Stricker; Mary M Machulda; David T Jones
Journal:  Arch Clin Neuropsychol       Date:  2022-08-23       Impact factor: 3.448

2.  Effort and neuropsychological performance in HIV-infected individuals on stable combination antiretroviral therapy.

Authors:  Robert Paul; Gina Rhee; Laurie M Baker; Florin Vaida; Sarah A Cooley; Beau M Ances
Journal:  J Neurovirol       Date:  2017-09-11       Impact factor: 2.643

3.  Validation of the Personality Assessment Inventory (PAI) scale of scales in a mixed clinical sample.

Authors:  Kaley Boress; Owen J Gaasedelen; Anna Croghan; Marcie King Johnson; Kristen Caraher; Michael R Basso; Douglas M Whiteside
Journal:  Clin Neuropsychol       Date:  2021-03-17       Impact factor: 4.373

4.  Replication and cross-validation of the personality assessment inventory (PAI) cognitive bias scale (CBS) in a mixed clinical sample.

Authors:  Kaley Boress; Owen J Gaasedelen; Anna Croghan; Marcie King Johnson; Kristen Caraher; Michael R Basso; Douglas M Whiteside
Journal:  Clin Neuropsychol       Date:  2021-02-22       Impact factor: 4.373

Review 5.  Effort, symptom validity testing, performance validity testing and traumatic brain injury.

Authors:  Erin D Bigler
Journal:  Brain Inj       Date:  2014-09-12       Impact factor: 2.311

6.  Baseline Cognitive Performance and Treatment Outcomes From Cognitive-Behavioral Therapies for Posttraumatic Stress Disorder: A Naturalistic Study.

Authors:  Kaloyan S Tanev; Lydia E Federico; Mark S Greenberg; Scott P Orr; Elizabeth M Goetter; Patricia A Resick; Roger K Pitman
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2020-01-17       Impact factor: 2.198

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.